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Abstract Acyl derivatives of type II PKS ACPs are required
for in vitro studies of polyketide biosynthesis. The presence of an
exposed cysteine residue prevented specific chemical acylation of
the phosphopantetheine thiol of the actinorhodin PKS holo ACP.
Acylation studies were further complicated by intramolecular
disulphide formation between cysteine 17 and the phosphopan-
tetheine. The presence of this intramolecular disulphide was
confirmed by tryptic digestion of the ACP followed by ESMS
analysis of the fragments. An act Cys17Ser ACP was engineered
by site-directed mutagenesis. S-Acyl adducts of act C17S,
oxytetracycline and griseusin holo ACPs were rapidly formed
by reaction with hexanoyl, 5-ketohexanoyl and protected
acetoacetyl imidazolides. Comparisons with type II FAS ACPs
were made.
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1. Introduction
Polyketides are a heterogeneous group of secondary meta-
bolic natural products possessing wide ranging pharmacolog-
ical activities [1]. Like the structurally and mechanistically
related fatty acid synthases (FASs) [2], polyketide synthases
(PKSs) catalyse repeated decarboxylative condensations be-
tween simple acyl thioesters. Each cycle results in the forma-
tion of a L-keto group and by selectively controlling the extent
of reduction of these groups PKSs generate great structural
variability [3].
PKSs of bacteria can be classi¢ed into two groups. Type I
synthases are large multifunctional proteins which catalyse the
biosynthesis of highly reduced polyketides such as the macro-
lide erythromycin [4]. Distinct catalytic sites are organised
linearly in such a way that the polyketide may be synthesised
using the enzymes in a non-repetitive manner. Type II syn-
thases catalyse the biosynthesis of aromatic polyketides in
streptomycetes. They are multienzyme complexes formed
from up to eight individual enzyme activities that function
iteratively. The L-keto groups of the intermediates formed
by these type II complexes remain largely unmodi¢ed allowing
the highly reactive polyketide backbone to undergo a series of
enzyme catalysed, regiospeci¢c cyclisations [5]. Understanding
the factors which control polyketide production, particularly
in the type II enzyme systems, is a major challenge in current
biosynthetic studies.
Several laboratories have recently generated a number of
hybrid polyketide synthases which have facilitated the analysis
of both modular [6,7], as well as aromatic PKSs [8]. Using
such genetics based combinatorial techniques a number of
novel compounds have been produced, the analysis of which
has enabled the enzymes responsible for controlling the spe-
ci¢city of individual reactions within the overall catalytic cycle
to be identi¢ed. Many of these deductions are largely infer-
ential, however, and are complicated by the fact that the ge-
netic experiments often fail to produce an isolable product.
Direct studies on isolated PKSs in vitro should provide
invaluable information, although to date relatively few intact
PKSs have been puri¢ed to homogeneity and examined. Ac-
tive cell-free preparations of both type I [9,10] and type II
PKS [11,12] enzymes have been demonstrated. A fully active
cell-free type II PKS, the tetracenomycin (tcm) producing
PKS from Streptomyces glaucescens, was identi¢ed in 1993
[11], while active preparations of both the complete actino-
rhodin (act) PKS from S. coelicolor, as well as a minimal
system have been obtained [12]. The fact that the type II
PKSs exist as an assembly of discrete proteins may make it
impossible to purify an intact PKS. In the light of this, con-
stituent proteins are being isolated individually in an attempt
to establish their physical and biochemical characteristics.
This should allow the reconstitution of combinations of these
isolated proteins in vitro, complementing the mix and match
genetic studies.
To date the best studied PKS protein is the acyl carrier
protein (ACP), which has been isolated (predominantly in
the inactive apo form) from a number of type II Streptomyces
systems [13,14]. Both the secondary structure [15] and three
dimensional solution structure [16] of the actinorhodin (act)
ACP have been determined by two dimensional (2D) NMR
techniques. The tertiary fold of apo act ACP shows a strong
structural homology with Escherichia coli FAS ACP for which
a solution structure is also available [17,18]. Both the PKS
and FAS ACPs consist of four helices which form a hydro-
phobic cleft capable of accommodating both the 4P-phospho-
pantetheine prosthetic group as well as an acyl chain. In the
case of the PKS protein, however, a number of hydrophilic
groups have been identi¢ed, buried within the core of the
protein which may play a role in the stabilisation of the grow-
ing polyketide chain [16]. A further di¡erence between the
PKS and FAS ACPs relates to the dynamic properties of
the two structures. The E. coli FAS ACP is thought to exist
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in two or more distinct conformations [19,20] while only a
single conformation has been observed for the PKS ACP
[16]. The signi¢cance of these ¢ndings is at present unknown,
but may re£ect the relative capacities of these proteins to
change conformations whilst accommodating their respective
acyl chains.
The interactions between the acyl chain and E. coli FAS
ACP have been extensively studied. The acyl binding cleft
encloses the ¢rst six to eight carbon atoms of the acyl chain
[21^23] reducing the hydrodynamic radius of the protein, and
rendering it more stable to expansion at alkaline pH. This
suggests that some interactions may exist between the acyl
chain and the amino acids within the binding cleft. Despite
these initial physical observations, two-dimensional NMR
studies of acyl ACP showed that the structural changes which
occur following acylation with fatty acids of eight carbon
atoms or less are small [24,25].
As part of our on-going study of the polyketide ACPs we
have set out to speci¢cally acylate puri¢ed type II PKS ACPs
with both fully reduced acyl chains, as well as polyketide
assembly intermediates, establishing the e⁄ciency of both
chemical and enzymic methods. This paper describes the acyl-
ation of act and other polyketide holo ACPs and their detailed
characterisation.
2. Materials and methods
2.1. ACP derivatisation and ESMS analysis
The apo and holo forms of griseusin, oxytetracycline, actinorhodin
and an actinorhodin cysteine 17 serine mutant (described in this pa-
per) PKS ACPs were expressed and isolated as previously described
using standard techniques [14,26]. For the derivatisation experiments
an aqueous solution of ACP (25 Wl at a concentration of 4 mg/ml),
adjusted for pH (range 5^9) by the addition of either dilute HCl or
ammonia, was treated with a molar equivalent of p-nitrophenyl disul-
phide (NPDS) in acetonitrile (5 Wl). This reaction was quenched by
the addition of a 25% formic acid solution (5 Wl) after a number of
timed intervals up to 1 h. Mass spectra were measured on a VG
Quattro spectrometer equipped with an electrospray source. Each
sample (20 Wl) was directly injected into the electrospray source via
a Rheodyne loop injector at a solvent (water:acetonitrile 50:50 v/v,
1% formic acid) £ow rate of 20 Wl/min. The mass spectrometer
was routinely scanned over the m/z range 800^1600 and this mass
range was calibrated using a solution of horse heart myoglobin
(20 pmol injections; Mr = 16951.48 Da). Wild type holo ACP solu-
tions containing a 5-fold excess of DTT were incubated at 37‡C for
30 min before desalting (FPLC G25 fast desalt column, Pharmacia)
using water at the pH at which the ESMS experiments were per-
formed. Analyses were carried out immediately. Imidazolide deriva-
tives were prepared using the methods described by Cronan and Kla-
ges [27] and ACP derivatisations carried out as with the NPDS
experiments.
2.2. ACP mutation procedure
ActI-ORF3 (ACP) was cloned as an XbaI fragment from pIJ 5467
into the XbaI site of pUC118. One clone, in which the actI-ORF3 ran
in the EcoRI to HindIII direction, was designated pRJCI117d. Two
synthetic oligo nucleotides were constructed (mutation site under-
lined): 5P-GACGGACGGGACGGACGTC-3P and 5P-TCACCGGC-
GTCTCCACGA-3P. 1.0 nmol of each was treated with 5 units of T4
polynucleotide kinase in a 10 Wl reaction for 45 min at 37‡C, the
reactions were then heat treated at 90‡C for 2 min. The oligonucleo-
tides (0.1 nmol of each) were used to prime a standard polymerase
chain reaction (PCR), containing pRJCI117d (0.2 Wg), 6% glycerol
and VENT DNA polymerase (1 unit). Temperature was cycled as
follows: 96‡C, 60 s, then 60‡C, 45 s, then 72‡C, 150 s, repeated 25
times, then 4‡C. The resultant synthetic linear plasmid DNA was
precipitated and resuspended in 100 WL H2O. 20 Wl of this solution
was digested with DpnI at 37‡C for 2 h. The DNA was precipitated
and resuspended in 50 Wl H2O. 8 Wl of this DNA was ligated in a 10 Wl
reaction with T4 DNA ligase (0.5 units) at 12‡C for 2 h. DNA was
precipitated and resuspended in 10 WL H2O. 4 Wl was electroporated
into E. coli JM101. The resultant cell suspension was spread for single
colonies on L agar containing 100 Wg/ml carbenicillin.
Twelve single colonies were picked for sequence analysis. Single
stranded DNA was generated using helper phage M13KO7, and pu-
ri¢ed prior to sequencing using the method of Boyle and Lew [28].
Sequencing was carried out by hand. The required mutation was
apparent in six out of 11 clones: no other mutations were observed.
One mutant clone was digested with NdeI and BamHI and the resul-
tant fragment subcloned into the NdeI and BamHI sites of the ex-
pression vector pT7-7. Expression of the resultant strain (pIJ2366)
was performed by standard procedures and derivatisation experiments
carried out exactly as for the non-mutated act ACP.
2.3. Tryptic digest of PKS ACPs
Wild type apo act ACP and holo act ACP (100 WM) were digested
with 2% (w/w) trypsin (sequencing grade, Sigma) in 100 mM
NH4HCO3 (pH8.0) for 4 h at 37‡C. 50 Wl of digested protein was
injected onto a C18 reverse phase HPLC column (0.4U240 mm, 300
Aî , Rainin) equilibrated in milli Q water containing 0.1% TFA. The
peptide fragments were eluted with a 0^100% acetonitrile+0.085%
TFA gradient (over 110 min) at 0.5 ml/min monitoring absorption
at 214 nm. Fractions containing peptide fragments were lyophilised,
resuspended in water:acetonitrile (50/50 v/v) containing 1% formic
acid and analysed by ESMS (20 Wl injections) as described previously.
2.4. Acyl ACP synthetase assay
Holo ACP (1 mg/ml, 15 Wl) was incubated with acyl ACP synthetase
(Sigma, 2 mU) at 37‡C for 1 h in Tris-HCl (100 mM, pH 8.0) con-
taining DTT (2 mM), ATP (5 mM), LiCl (0.4 M), Triton X-100 (2%),
palmitic acid (3 mM) and 14C-labelled palmitic acid (2 Wl stock sol-
ution, speci¢c activity 824 mCi/mmol), in a ¢nal volume of 50 Wl. An
aliquot (25 Wl) of the incubation mixture was spotted onto the end of
a 10 cm strip of Whatman 3MM ¢lter paper and excess, unbound
radiolabel eluted away from the radiolabelled ACP using a chloro-
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Table 1
Masses of chemically acylated derivatives of holo gris and otc ACPs
Acyl group Holo gris ACPa Holo otc ACPb
Expected mass (Da) Observed mass (Da) Expected mass (Da) Observed mass (Da)
^ 9 885 9 886.8 þ 1.0 10 254 10 257.8 þ 1.5
10 016 10 015.9 þ 2.9
Hexanoyl 9 982 9 982 þ 2.0 10 352 10 352.2 þ 0.6
10 113 10 116.0 þ 1.3 10 450 10 451.1 þ 2.9
5-Ketohexanoyl 9 996 9 996.7 þ 1.3 10 366 10 367.8 þ 1.7
10 127 10 127.8 þ 2.9 10 478 10 481.4 þ 1.2
Protected acetoacetyl 10 013 10 013.9 þ 3.9 10 383 10 385.6 þ 1.1
10 144 10 144.0 þ 0.7 10 512 10 515.4 þ 1.3
aGris ACP exists in two forms as a result of partial endoproteolytic cleavage of the N-terminal methionine and so two peak series were obtained in
each ESMS spectrum.
bOtc ACP has an exposed cysteine residue. Formation of mono and bis adducts by acylation of both the 4P-phosphopantetheine and the cysteine
(Cys-16) thiols was observed.
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form:methanol:acetic acid (3:6:1 v/v) mixture. After the ¢lter papers
had dried thoroughly the washing procedure was repeated and the
papers dried again. The ¢lter papers were then cut into 2.5 cm sec-
tions, placed in scintillation £uid, and counted for radioactivity. Com-
mercially available E. coli ACP (Sigma) was used as a control in these
experiments.
3. Results and discussion
Our knowledge of the factors controlling the type II poly-
ketide synthase complex has progressed rapidly over the past
few years with the demonstration that novel aromatic com-
pounds can be genetically engineered through the combinato-
rial manipulation of PKS subunits [7,8]. Attempts to repeat
these combinatorial studies in vitro in order to provide an
alternative route for the controlled synthesis of novel polyke-
tides have been hampered by the intrinsic nature of bacterial
type II systems. Puri¢cation or reconstitution of the complete
PKS complex has not been reported, although active cell-free
systems have been obtained [11,12]. At least one individual
Streptomyces type II PKS component, the acyl carrier protein
has been successfully expressed in E. coli, puri¢ed [13,14],
obtained predominantly in an active holo form [26] and a
3 dimensional solution structure solved [16]. In this paper
we have further characterised the actinorhodin PKS ACP
and demonstrated that acylation of this and other type II
PKS ACPs can be accomplished using chemical techniques
previously used to derivatise FAS ACPs [27].
The thiol speci¢c reagent NPDS reacted rapidly with the
apo form of act ACP. ESMS analysis showed greater than
90% addition of nitrophenyl sulphide (NPS) to this ACP spe-
cies occurred after 5 min incubation at pH 6^8 (Fig. 1). At pH
5, 60^65% was derivatised after 5 min, rising to 90% after 1 h,
suggesting a slight pH e¡ect on this reaction. These experi-
ments show that apo act ACP contains an exposed thiol
group. In the absence of the phosphopantetheine co-factor
the only candidate is cysteine 17. This amino acid has been
previously implicated in the rapid dimerisation of both actino-
rhodin and oxytetracycline (otc) apo ACPs [14]. Surprisingly,
initial ESMS analyses of holo act ACP after incubation with
NPDS showed no addition of NPS to the protein if the reac-
tion was carried out at pH 7 or higher. A mass of 9455.5 þ 1.5
was obtained, corresponding to the expected mass of the holo
protein. In this case neither the cysteine thiol nor the 4P-phos-
phopantetheine thiol were chemically modi¢ed. Pre-treatment
of the holo protein with DTT followed by complete removal
of the excess reducing agent by desalting into a pH5 bu¡ered
solution allowed addition of two NPS groups to the protein,
but only if the derivatisation was carried out immediately
after the desalting process (expected Mr = 9763 for 2 additions
of NPS; observed Mr = 9763.2 þ 1.1). Thirty minutes after de-
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Fig. 2. Ribbon representation of the solution structure of holo act
ACP showing the disulphide bond between the 4P-phosphopante-
theine prosthetic group and cysteine 17. The 4P-phosphopantetheine
chain was modelled onto the structure of the ACP using Insight II.
Fig. 1. ESMS spectrum of the reaction of NPDS with the apo ACP. A: apo act ACP, expected Mr = 9117, observed = 9116.10 þ 1.0; B: NPS-
apo act ACP: expected Mr = 9270, observed = 9269 þ 0.7.
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salting, the holo ACP was again unreactive in the presence of
NPDS. When comparing NPS addition to both holo and apo
act ACPs the addition to the 4P-phosphopantetheine thiol oc-
curred slightly faster than to the exposed cysteine thiol. This is
possibly due to greater accessibility of the terminal thiol group
of the exposed prosthetic group in solution. The relative dif-
ference in reactivity of the 4P-phosphopantetheine and cysteine
thiols was small, however, suggesting that chemical discrimi-
nation between these groups on this basis was not possible.
The results showing no addition of NPS to holo act ACP
are consistent with the formation of an intramolecular disul-
phide bond between the 4P-phosphopantetheine and cysteine
thiols rendering these groups inaccessible to chemical modi¢-
cation (Fig. 2). To con¢rm this both apo and holo act ACP
were subjected to tryptic digestion. The resulting fragments
were separated by HPLC and analysed by ESMS. Of the
predicted eight fragments only the fragment consisting of a
single arginine residue (Arg-12) was unidenti¢ed.
The elution times and observed masses of fragments 5, 7, 6,
1, 3, and 8 (in order of increasing retention time) are identical
for both the apo and holo proteins, although there is an over-
all reduction in the area of the peak corresponding to frag-
ment 3 (the fragment containing cysteine 17) in the holo digest
when compared with that of the apo protein (Fig. 3). Signi¢-
cant di¡erences between the HPLC analyses of the apo and
holo ACP digests were only seen with regard to fragment 4
which contains serine 42. Fragment 4 obtained from the apo
protein incubation and lacking the 4P-phosphopantetheine co-
factor, eluted at 62 min. The same fragment isolated from the
holo ACP incubation and therefore phosphopantetheinylated
eluted slightly earlier at 59 min. HPLC analysis of the holo
digest also included a second peak not present in the apo ACP
incubation (Rt = 64.2 min). ESMS analysis gave m/z values of
1514.2, 1134.9 and 908.9 Da (for M+3H, M+4H and M+5H)
which correspond exactly to the values predicted for frag-
ments 3 (containing cysteine 17) and 4 linked by the 4P-phos-
phopantetheine chain.
In contrast to the holo act ACP, holo otc ACP, which also
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Fig. 4. ESMS spectrum of holo gris ACP showing presence of intermolecular dimers. A: Minus methionine dimer (3Met)2, expected
Mr = 19768, observed = 19770.4 þ 5.7; B: mixed plus-minus methionine dimer ( þ Met)2 : expected Mr = 19899, observed = 19901.3 þ 2.3; C: plus
methionine dimer (+Met)2 : expected Mr = 20030, observed = 20034.1 þ 2.6.
Fig. 3. HPLC analysis of trypsin proteolytic fragments from holo
act ACP. Fragment 4 elutes earlier for holo ACP (Rt = 59.4) com-
pared to apo ACP (Rt = 62.2) due the presence of the 4P-phospho-
pantetheine group (ESMS analysis F4 + 4PPP expected Mr = 1122.1
for (M+2H); observed Mr = 1122.1 þ 0.6). An extra fragment due to
fragment 3 coupled to fragment 4 by the 4P-phosphopantetheine
group (Rt = 64.2) is present only in the holo ACP HPLC trace
(ESMS analysis expected Mr = 1514.2 (M+3H), 1134.9 (M+4H),
908.9 (M+5H); observed Mr = 1514.1, 1135.3, 912.6).
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has an exposed cysteine (Cys-16), did not readily form an
intramolecular disulphide. The length of the 4P-phosphopan-
tetheine side chain has been established as 20 Aî [2], while the
distance between the cysteine (Cys-17) and the serine (Ser-42)
bearing the prosthetic group is approximately 12.4 Aî for the
act protein (unpublished results). By comparison, the distance
between cysteine 16 and serine 41 in the otc ACP is 11.2 Aî ,
yet no evidence for formation of an intramolecular disulphide
has been observed. The overall global fold for the otc ACP is
very similar to that of the act ACP (unpublished results) dif-
fering most markedly at the C-terminal end where the otc
ACP has an additional 12 amino acid sequence which adopts
no de¢nite conformation. Clearly then the development of the
intra-molecular disulphide is possible where distance is the
only consideration. Its absence in the otc ACP suggest that
other factors may prevent its formation. Holo gris ACP does
not contain any cysteine residues and would not therefore be
expected to form an intramolecular disulphide. Three distinct
dimers were, however, seen for the holo gris protein, corre-
sponding to the holo minus methionine dimer, the holo plus
methionine dimer, and the mixed holo plus, holo minus me-
thionine dimer (Fig. 4). Such intermolecular dimers form
readily and are observable on native gels, but this is the ¢rst
instance that such dimeric ACP species have been reported to
survive the ESMS analysis conditions.
N-Acyl imidazolides have previously been used to chemi-
cally acylate the E. coli holo FAS ACP [27] and the S. eryth-
raea putative holo FAS ACP [29]. Such acylations are speci¢c
for the 4P-phosphopantetheine (exposed cysteine residues are
not present in FAS ACP) and result in acyl ACPs whose
physical and biological properties are indistinguishable from
enzymically prepared substrates. At equimolar concentrations
of hexanoyl imidazolide and ACP, mono acylation of the apo
act protein was evident within 10 min (expected Mr = 9216;
observed Mr = 9220.4 þ 3.8). Following DTT treatment, rapid
formation of the diacylated derivative of holo act ACP was
observed (expected Mr = 9654; observed Mr = 9652.2 þ 0.8).
This suggests that chemical acylation will not distinguish be-
tween the exposed cysteine and 4P-phosphopantetheine thiols
con¢rming results obtained using the thiol speci¢c reagent,
NPDS. Such chemically formed diacylated species would be
of little use either as substrates for other PKS enzymes, or in
any studies of the interactions that the acyl chain has with
speci¢c amino acids of the protein.
In order to avoid the formation of bis adducts in the chem-
ical acylation studies, or the development of the unreactive
cysteine-phosphopantetheine disulphide, cysteine 17 of act
ACP was mutated to a serine by site-directed mutagenesis.
This mutation did not signi¢cantly a¡ect the puri¢cation of
the act PKS ACP and levels of protein isolated were analo-
gous to those found for the native protein. The C17S mutated
ACP could also substitute for the wild type act ACP forming
an active minimal PKS system (act ketosynthase, act chain
length factor, plus act acyl carrier protein), suggesting that
the amino acid mutation has not signi¢cantly a¡ected the
interactions between the PKS components (unpublished re-
sults). ESMS analysis con¢rmed the single amino acid mod-
i¢cation. The apo form of the C17S mutated ACP did not
react with NPDS (expected Mr = 9101; observed
Mr = 9103.1 þ 2.0) consistent with the removal of the exposed
reactive cysteine thiol, while a single NPS addition to the holo
form of the C17S ACP was identi¢ed (expected Mr = 9594;
observed Mr = 9596.8 þ 0.8). Similarly, apo act C17S ACP did
not react with hexanoyl imidazolide at equimolar concentra-
tions, while holo act C17S ACP formed a mono-acylated spe-
cies. This acylated ACP did not react further with the NPDS
indicating that acylation had occurred speci¢cally on the thiol
of the 4P-phosphopantetheine cofactor.
Chemical derivatisation of the holo act C17S ACP with the
reduced triketide analogue, 5-ketohexanoyl imidazolide (ex-
pected Mr = 9557; observed Mr 9555.2 þ 0.8) (Fig. 5), as well
as the ethylene ketal protected form of the acetoacetyl dike-
tide, 3-oxo-(1,2-ethanediol acetal)-butanoyl imidazolide (ex-
pected Mr = 9570; observed Mr = 9572.5 þ 2.0) also proved
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Fig. 5. ESMS spectrum of the reaction of 5P-ketohexanoyl imidazolide with holo ACP. A: holo act C17S ACP: expected Mr = 9445, ob-
served = 9444.6 þ 2.0; B: 5P-ketohexanoyl-holo act C17S ACP: expected Mr = 9557, observed = 9555.2 þ 0.8.
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successful, with 90% acylation occurring after 15 min. Ace-
toacetyl ACP is an excellent target for the study of both
polyketide and fatty acid biosynthesis as it is the product of
the ¢rst condensation reaction in both pathways. Although
previously synthesised as its imidazolide derivative [30] this
compound proved di⁄cult to isolate in useful quantities and
consequently the protected form was used in these experi-
ments. Unfortunately incubation of the protected acetoacetyl
derivative of the ACP under mild acidic conditions failed to
remove the protecting group to yield acetoacetyl ACP. Both
holo gris and holo otc ACPs were also successfully acylated
using these acyl imidazolides (Table 1). As expected, in the
case of the holo otc ACP a double acylation was observed as
both cysteine and 4P-phosphopantetheine thiols are present.
As was seen for the act ACP the relative di¡erence in reac-
tivity of the otc ACP 4P-phosphopantetheine and cysteine thi-
ols was small. Thus chemical derivatisation methods are
capable of speci¢cally acylating polyketide ACPs with func-
tionalised as well as fatty acid intermediates.
The exposed cysteine, which is present in four out of the six
type II Streptomyces PKS ACPs isolated to date, would not
interfere with the speci¢c acylation of the 4P-phosphopante-
theine thiol if an acyl transferase were used to catalyze this
reaction. This would eliminate the necessity for the modi¢ca-
tion of an amino acid which could potentially play a role in
interprotein interactions within the PKS. No discrete acyl-
transferase domain has yet been identi¢ed in the gene clusters
encoding type II PKSs. Malonyl co-enzyme A transacylase
genes have, however, been identi¢ed in the putative FAS clus-
ters of S. glaucescens [31] and S. coelicolor [32]. These genes
encode enzymes reportedly capable of transferring the malo-
nate of malonyl coenzyme A to both FAS as well as PKS
ACPs, but whether these enzymes have a broad enough sub-
strate speci¢city to prove synthetically useful in PKS ACP
acylation is still unknown. Acyl derivatives of FAS ACPs
have been synthesised enzymically using acyl ACP synthetase
from E. coli although yields using short acyl chains (6C12)
are poor [22]. For this reason chemical derivatisation using
short acyl imidazolides has become the method of choice.
Acyl ACP synthetase is most e⁄cient at ligating C14-C18 fatty
acids to FAS ACPs with the retention of stable, native protein
structure although the e⁄cacy of this enzyme on PKS ACPs
was not known. When commercially available E. coli acyl
ACP synthetase was used in an attempt to monoacylate
wild type holo act ACP, holo act C17S ACP, as well as holo
otc ACP with palmitic acid, none of the PKS ACPs examined
were enzymically acylated even after prolonged incubation
times although in control experiments E. coli FAS ACP
served as an e⁄cient substrate. This may indicate that
although the gross 3 dimensional structures of PKS and
FAS ACPs are similar [15], subtle di¡erences exist which
may prevent adequate enzyme interactions. Only acylation
using palmitic acid has been investigated, however, and there-
fore the enzyme catalysed transfer of shorter carbon chains
lengths cannot be rigorously excluded by these experiments.
Recently, however, we have managed to form both malonyl as
well as acetoacetyl ACPs directly from both co-enzyme A as
well as N-acetyl cysteamine derivatives [33]. Initial results sug-
gest that this self catalysed transfer may be a unique property
of the polyketide ACPs. This may explain the fact that an
active acyl transferase has not been identi¢ed in PKS enzyme
clusters and may give some insight in to the early events
occurring in polyketide biosynthesis.
The ability to speci¢cally acylate PKS ACPs by chemical
methods will prove invaluable in studies to determine struc-
tural changes induced in the protein by interactions of the acyl
chain with speci¢c amino acids within the binding cleft. Using
this technique milligram quantities of acyl ACP can be rapidly
obtained. Highly functionalised polyketide intermediates may
need some form of functional group protection to prevent
spontaneous cyclisation or to aid acyl imidazolide formation
prior to derivatisation of the protein. Removal of such pro-
tecting groups once bound to the protein may prove di⁄cult,
however, if the native structure is to remain intact.
Finally, appropriate acyl ACPs will be prepared for use as
substrates to probe the speci¢city of other PKS enzymes. In
this way further information on the factors controlling poly-
ketide biosynthesis may be obtained and novel polyketide
structures produced in vitro.
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